Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) today announced its unaudited consolidated financial results for the quarter ended September 30, 2013 under International Financial Reporting Standards (IFRS).
Key Highlights (Q2 FY14)
•Consolidated revenues at Rs. 33.6 billion, YoY growth of 17%.
Help employers find you! Check out all the jobs and post your resume.
